Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-09-012215
Filing Date
2009-02-26
Accepted
2009-02-25 20:50:13
Documents
15
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a09-1524_110k.htm 10-K 2392540
2 EX-10.28 a09-1524_1ex10d28.htm EX-10.28 183863
3 EX-10.35 a09-1524_1ex10d35.htm EX-10.35 101551
4 EX-10.40 a09-1524_1ex10d40.htm EX-10.40 151740
5 EX-10.41 a09-1524_1ex10d41.htm EX-10.41 731494
6 EX-21.1 a09-1524_1ex21d1.htm EX-21.1 2710
7 EX-23.1 a09-1524_1ex23d1.htm EX-23.1 3375
8 EX-31.1 a09-1524_1ex31d1.htm EX-31.1 12473
9 EX-31.2 a09-1524_1ex31d2.htm EX-31.2 12424
10 EX-32.1 a09-1524_1ex32d1.htm EX-32.1 7643
11 GRAPHIC g15241kg01i001.jpg GRAPHIC 3174
12 GRAPHIC g15241ba01i001.jpg GRAPHIC 79863
13 GRAPHIC g15241ba01i002.jpg GRAPHIC 1361
14 GRAPHIC g15241ba07i001.gif GRAPHIC 3365
15 GRAPHIC g15241kg03i001.jpg GRAPHIC 3174
  Complete submission text file 0001104659-09-012215.txt   3727247
Mailing Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008
Business Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19125 | Film No.: 09635397
SIC: 2834 Pharmaceutical Preparations